|Study Type:||Phase I|
|Stage:||Follow up complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1 clinical trial to evaluate the safety, pharmacokinetics, and anti-viral activity of VRC HIVMAB060 00 AB (VRC01) and VRC HIVMAB080 00 AB (VRC01LS) in the serum and mucosa of healthy, HIV-uninfected adult participants
HVTN 116 is a Phase I clinical trial to evaluate the safety and immunogenicity of VRC HIVMAB060 00 AB (VRC01 mAb) and VRC HIVMAB080 00 AB (VRC01LS mAb).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.